Aikido Pharma Inc Stock News

AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that it will be presenting at the LD 500 investor conference on Thursday, September 3, 2020 at 11:20 a.m. ET. Anthony Haye

AIkido Pharma Inc. (Nasdaq: AIKI) today announced it has extended its previously disclosed exclusive option agreement ("Option") with the University of Maryland, Baltimore (UMB) for the technology set

LOS ANGELES, CA / ACCESSWIRE / August 5, 2020 / LD Micro today announced the initial list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively onlin

AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that on July 31, 2020, the Company received a letter from the Listing Qualifications Department of The NASDAQ Stock Market

AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today provided an update on its effort to identify compounds to potentially address the COVID-19 pandemic. As previously announced, on Apr

AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced an update to its machine learning driven pancreatic cancer research.

AIkido Pharma Inc. (Nasdaq: AIKI) today announced publication of a paper: The Novel Phospholipid Mimetic KPC34 Is Highly Active Against Acute Myeloid Leukemia with Activated Protein Kinase C by Peter

AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that the distribution of the previously announced Hoth Therapeutics, Inc. ("Hoth") stock dividend, has commenced and stock

AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that Hoth Therapeutics Inc. registered the stock to be distributed on April 3 2020.(https://www.sec.gov/Archives/edgar/dat

AIkido Pharma Inc. (Nasdaq: AIKI) today announced execution of an Artificial Intelligence (AI), and Machine Learning (ML) research agreement with Cogia Biotech LTD ("Cogia") (www.cogia.de) to accelera

AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that the distribution date for the previously announced distribution to our stockholders of shares of Hoth Therapeutics, I

AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced a reminder to the Company's stockholders that today, April 30, 2020, is the record date for the previously announced distr

Genentech's Ocrevus, Teva's Copaxone, and Biogen's Tecfidera score the top three share positions among patients who recently switched to a different disease-modifying therapy (DMT). The diverse clinic

AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that on April 13, 2020, the Company executed a Master License Agreement (the "License Agreement") with the University of M

AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that the record date for the previously announced distribution to our stockholders of shares of Hoth Therapeutics, Inc. ("